Log In Sign Up

Philips Webinars Live - Coronary ISR Management Strategies

  • 08 Oct 2020 America/Chicago


In-stent Restenosis (ISR)



Royal Philips is a diversified technology company, focused on improving people’s lives through meaningful innovation. With a century of history and more than 450 innovative products and services, we are ready to meet today’s challenges in healthcare by creating solutions that deliver better care to more people at lower cost.

Liu Wei

Chief Physician, department of Cardiology, Beijing Anzhen Hospital, Capital Medical University; Trained in cardiology and interventional cardiology in Tan Tock Seng Hospital of Singapore (2002-2006) , Omori hospital of Toho University in Japan(2009-2010), DeBakey cardiovascular center of Methodist hospital of Texas medical center in Houston and the department of medicine of University of...Read More

Link to profile Follow

Won-Jang Kim

Won-Jang Kim, MD, PhD is Assistant Professor, Cardiology at CHA Bundang Medical Center, Korea. His research interests are coronary artery intervention, contrast-induced nephropathy, aortic valve disease, valvular heart disease intervention, congenital heart disease intervention, noninvasive image including CT, MRI, PET, FFR-CT. He is a JKMA review board member since 2013 and also EC...Read More

Link to profile Follow

Tom Devasia

Dr. Tom Devasia is Professor and Unit Chief in the Department of Cardiology at Kasturba Hospital, Manipal, in the state of Karnataka. He also visits the TMA Pai Hospital in Udupi twice a week. As an Interventional Cardiologist, Dr. Devasia has wide experience in both structural and coronary intervention, in both adult and paediatric age groups. He is well experienced in complex procedures...Read More

Link to profile Follow